Franklin Genomic Advancements ETF (HELX)

• Market cap: $11.3M
• 1 day: 0.46%
• 5 days: 2.13%
• 1 month: -7.66%
• 3 months: -1.80%
• 6 months: -15.20%
• Year to date: -2.34%
• 1 year: -12.64%
• 5 years: 39.33%
• 10 years: 18.28%

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

92% more capital invested

Capital invested by funds: $1.55M [Q3] → $2.97M (+$1.43M) [Q4]

67% more funds holding

Funds holding: 6 [Q3] → 10 (+4) [Q4]

7.01% more ownership

Funds ownership: 15.89% [Q3] → 22.9% (+7.01%) [Q4]